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Abstract
Background: Suicidal behaviour is known to aggregate in families. Patients with psychiatric disorders are at higher
risk for suicide attempts (SA), however protective and risk genetic variants for suicide appear to be independent of
underlying psychiatric disorders. Here we investigate genetic variants in genes important for neurobiological
pathways linked to suicidal behaviour and/or associated endophenotypes, for association with SA among patients
with co-existing psychiatric illness. Selected gene-gene and gene-environment interactions were also tested.
Methods: DNA was obtained from bloods of 159 patients (76 suicide attempters and 83 non-attempters), who
were profiled for DSM-IV Axis I psychiatric diagnosis. Twenty-eight single nucleotide polymorphisms (SNPs) from 18
candidate genes (COMT, 5-HT2A, 5-HT1A, 5-HTR1B, TPH1, MAO-A, TPH2, DBH, CNR1, BDNF, ABCG1, GABRA5, GABRG2,
GABRB2, SLC1A2, SLC1A3, NTRK2, CRHR1) were genotyped. Genotyping was performed by KBioscience. Tests of
association between genetic variants and SA were conducted using Chi squared and Armitage Trend tests. Binary
logistical regression analyses were performed to evaluate the contribution of individual genetic variants to the
prediction of SA, and to examine SNPs for potential gene-gene and gene-environment interactions.
Results: Our analysis identified 4 SNPs (rs4755404, rs2269272, rs6296 and rs1659400), which showed evidence of
association with SA compared to a non-attempter control group. We provide evidence of a 3-locus gene-gene
interaction, and a putative gene-environment interaction, whereby genetic variation at the NTRK2 locus may
moderate the risk associated with history of childhood abuse.
Conclusion: Preliminary findings suggest that allelic variability in SLC1A2/3, 5-HTR1B and NTRK2 may be relevant to
the underlying diathesis for suicidal acts.
Background
Suicide represents a worldwide public health problem
and is a leading cause of death among those aged 15-44
years in many developed countries, representing a signif-
icant social and economic burden http://www.who.int/
mental_health/prevention/suicide. According to the
stress-diathesis model of suicidal behaviour, risk of
suicide is not exclusively determined by a psychiatric ill-
ness (or an alternative stressor), but rather that indivi-
duals may have a predisposition or tendency towards
suicidal ideation, which is aggravated further by one or
more stressors [1]. A greater understanding of clinical
and biological risk factors will help us understand more
fully this model of suicidal behaviour and inform new
therapies and tailored interventions.
The molecular pathology of suicidal behaviour
remains complex; epidemiological studies have demon-
strated familial clustering of suicide and suicidal beha-
viour [2]. Meta-analysis of published twin case studies
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cide and for suicidal behaviour in monozygotic (MZ)
versus dizygotic (DZ) twins, establishing a solid genetic
link [3]. Currently, risk assessment of suicidal behaviour
relies heavily on clinical variables [4]. Indeed, patients
with psychiatric disorders are at higher risk for suicide
attempt (SA) [5-8], however protective and risk genetic
variants for suicide appear to be independent of under-
lying psychiatric disorders [9-11]. Identifying relevant
genetic variants or single nucleotide polymorphisms
(SNPs) in genes intimately linked to various neurobiolo-
gical pathways, whose alteration may contribute to suici-
dal behaviour, may provide insight into the etiological
processes that underlie suicidal behaviour and identify
novel biological therapeutic targets.
Numerous neurobiological pathways have been impli-
cated in the etiology of suicide and suicidal behaviour.
Deregulation of the monoaminergic transmitter systems
(norepinephrine, dopamine and serotonin) [12,13],
gamma aminobutyric acid (GABA) inhibitory neuro-
transmitter system [14,15], glutamatergic excitatory neu-
rotransmitter system [14,15], lipid metabolism [16,17],
cannabinoid system [18] and neurotrophic signalling
factors [19] are linked to suicidal behaviour. Interest-
ingly, the hypothalamic-pituitary-adrenal (HPA) axis
m a yb ei n v o l v e di ni n c r e a s e ds u i c i d a lb e h a v i o u ri n
response to adversity during development [20], hence
highlighting the contribution of early environmental fac-
tors to suicide risk.
Suicidal behaviour is a complex trait; therefore it is
likely to be the result of a combination of numerous
environmental and genetic factors with an added layer
of complexity via potential gene-gene (GxG) and gene-
environment (GxE) interaction effects [21]. Conse-
quently, investigating the relationship between genetic
variants and environmental factors (e.g. childhood abuse
or alcoholism) is an important step towards elucidating
the mechanisms behind suicidal behaviour.
Here we test the hypothesis that genetic variants in
candidate genes important for neurobiological pathways
linked to suicidal behaviour and/or associated endophe-
notypes, may confer a protective [22] or risk effect on
SA among patients with co-existing psychiatric illness
(suicide attempters versus non-attempter controls). In
addition to main genetic effects, we also tested selected
GxG and GxE interactions for association with SA.
Methods
Clinical sample collection
The study consisted of 159 psychiatric patients recruited
as part of the Ireland North/South Urban/Rural Epide-
miologic (INSURE) collaborative project [23]. Briefly,
consecutive newly referred patients to six Community
Psychiatric Clinics on the island of Ireland (Donegal,
Belfast, Omagh, Dublin, Portlaoise and Ballinasloe) were
invited to take part in a clinical and molecular genetics
study of suicidal behaviour in major psychiatric disorders
over a year long recruitment period. In total, 159 patients
gave written informed consent for the study. Patients
were interviewed for Axis I Psychiatric Disorders using
the Structured Clinical Interview for DSM-IV [24]. His-
tory of attempted suicide was recorded using the Colum-
bia University Suicide History Questionnaire [25], which
incorporates the Scale for Suicide Ideation [26], and the
Suicide Intent Scale [27]. A suicide attempt was defined
as a completed act of self-harm with at least some
expressed intent to die (scoring at least 1 on item 10 of
Suicide Intent Scale [27]). Seventy-six (48% Male, 52%
Female; Mean age: 34.7 yrs) had a history of SA and 83
(61.4% Male, 38.6% Female; Mean age: 40.7 yrs) had not.
Childhood abuse was defined as the presence or absence
of a history of sexual and/or physical abuse under the age
of 16. Further clinical variables from clinical and demo-
graphic assessments are outlined in Table 1. All clinical
research interviews were performed by a trained research
psychiatrist or research psychiatric nurse. Ethics approval
was obtained for the study from the St Vincent’sH e a l t h -
care Group Ethics and Medical Research Committee.
Gene and SNP selection
In this study, genes intimately linked to numerous neuro-
biological pathways considered important for the patho-
genesis of suicide and/or associated disorders or
endophenotypes, were selected. Genes from the following
pathways were considered, monoaminergic transmitter
systems (norepinephrine, dopamine and serotonin), GABA
inhibitory neurotransmitter system, glutamatergic excita-
tory neurotransmitter system, HPA axis and cannabinoid
system. Genes important for cholesterol transport and
neural growth and differentiation were also selected.
Twenty-eight SNPs from the 18 selected genes (COMT,
5-HT2A, 5-HT1A, 5-HTR1B, TPH1, MAO-A, TPH2, DBH,
CNR1, BDNF, ABCG1, GABRA5, GABRG2, GABRB2,
SLC1A2, SLC1A3, NTRK2, CRHR1)w e r ei n c l u d e di no u r
analysis. SNPs, within these 18 genes, were screened for
known genetic associations with suicide, suicidal beha-
viour and/or associated endophenotypes using biomedical
online resources PubMed http://www.ncbi.nlm.nih.gov/
pubmed and OMIM http://www.ncbi.nlm.nih.gov/omim.
Priority was given to functional SNPs or SNPs within
regulatory regions utilising online genetic databases
ensembl http://www.ensembl.org/index.html and DbSNP
http://www.ncbi.nlm.nih.gov/projects/SNP/.
Genotyping
DNA was extracted from patient blood samples using
standard techniques. Flanking SNP sequences were
obtained from DbSNP and all genotyping assays were
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UK). Genotyping for SNP analysis was performed by
KBioscience using the competitive allele specific PCR
(KASP) chemistry coupled with a FRET-based genotyp-
ing system http://www.kbioscience.co.uk/reagents/
KASP/KASP.html. Genotyping data was viewed using
SNPviewer (KBioscience, Hertfordshire, UK), allowing
graphical viewing of the clusters that group the allele
calls.
SNPs in linkage disequilibrium (LD) with SNPs of
interest were identified using a combination of informa-
tion from Ensembl http://www.ensembl.org/index.html
and Haploview http://www.broadinstitute.org/haploview/
haploview.
Data analysis
Deviations from Hardy Weinberg Equilibrium (HWE)
were calculated using the exact test implemented by
SNP and Variation Suite (SVS) 7 software (Bozeman,
MT 59718 USA; http://www.goldenhelix.com/SNP_Var-
iation/svstrial.html).
Statistical tests of association examining the relation-
ship between patient’s alleles or genotype, at each of the
28 genetic loci, and suicide attempt were performed
using Pearson’s Chi-square test or Fisher’s exact test
( w h e nc o u n t sa r el o w ) .T h i sa n a l y s i sw a sp e r f o r m e d
both in SPSS and SNP and Variation Suite for verifica-
tion purposes.
SNPs which showed a modest level of association in
the original allelic and genotype tests of association
(P < 0.1) and one SNP which showed a gender specific
association with SA, were further analysed by applying
four genotype models (Additive (XX = 0, XY = 1,
YY = 2), Dominant (XX = 0, XY & YY = 1), Over-
dominant (XX & YY = 0, XY = 1) and Recessive (XX
& XY = 0, YY = 1); X = Major allele, Y = Minor
allele). For all models, except the additive model,
Pearson’s Chi-square test of association was used. For
the additive model an exact Armitage trend test was
preformed. Binary logistical regression analyses were
performed to evaluate the contribution of the geno-
type model associated with SA at each locus in the
prediction of attempted suicide, correcting for poten-
tial confounders such as age, gender and certain psy-
chiatric disorders and to interrogate associated SNPs
for potential GxG and GxE interactions. Analysis of
potential GxE interactions were applied to SNPs with
evidence of association in at least one genetic model
(n = 3) and to one SNP which showed evidence of
association in a gender specific manner (n = 1) and
not examined for all candidate SNPs listed in this
study. In addition, GXG interactions analysis was per-
formed on these 4 SNPs, which showed evidence of
association with SA and not examined for all candi-
date SNP listed in this study.
A non-parametric Mann-Whitney test was used to
calculate the difference in age between cases and con-
trols. For all other comparisons of clinical and demo-
graphic variables a Fisher’s exact test or Chi-squared
test of association was used. All statistical analysis was
performed on SPSS (PASW statistics 18, Chicago, Illi-
nois, USA) and genotypic associations verified using
SNP and Variation Suite (SVS) 7 software. For all tests,
significance was ascribed at P < 0.05.
Table 1 DSM-IV psychiatric diagnosis and clinical features of patient samples
Attempter (n = 76) n (%*) Non-attempter (n = 83) n (%*) P Value
Sex 0.124
Male 36(48) 51 (61.4)
Female 39 (52) 32 (38.6)
Mean age (years) 34.7 40.7 0.017
Positive 1st degree family history of suicide attempt 26 (35.6) 14 (17.1) 0.014
Child abuse (Physical and/or sexual) 37 (49.3) 27 (32.5) 0.047
Axis I Diagnosis 42 (55.3) 36 (43.4) 0.18
Substance-related disorders 24 (31.6) 21 (25.3) 0.334
Substance abuse/dependence 38 (50) 29 (34.9) 0.078
Alcohol abuse/dependence 6 (8.8) 7 (8.6) 1
Schizophrenia and other psychotic disorders
Bipolar disorders 5 (7.4) 4 (4.8) 0.786
Major depressive disorder 48 (63.2) 37 (44.6) 0.022
Anxiety disorders 32 (42.7) 25 (30.1) 0.14
Eating disorders 1 (1.3) 0 (0) 0.965
§P value was determined by Fishers exact or Chi squared test in all comparisons, with the exception of age, where a non-parametric Mann-Whitney test was
used to determine the P Value. *Illustrated percentages of variables are calculated for valid cases/controls only. In some cases certain clinical or demographic
variables could not be obtained from patients charts.
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Clinical and psychological features of study population
The mean age of the suicide attempter and non-attemp-
ter groups was significantly different (34.72 years versus
40.67 years, respectively, (P = 0.017)). The SA group
were more likely to have a diagnosis of major depressive
disorder (P = 0.022), a positive first degree family his-
tory of attempted suicide (P = 0.014), and a history of
child abuse (physical or sexual) (P = 0.047). No other
demographic or clinical variables were statistically differ-
ent between the two groups (Table 1).
Candidate gene selection
In this study, genes considered important in various
neurobiological pathways associated with suicide and/or
associated disorders or endophenotypes were chosen.
Overall, 18 genes were selected for inclusion in our ana-
lysis. The majority of genes (n = 8; COMT, 5-HT2A, 5-
HT1A, 5-HTR1B, TPH1, MAO-A, TPH2, DBH)a r e
important for monoaminergic transmitter systems (nore-
pinephrine, dopamine and serotonin). Key genes of the
GABA inhibitory neurotransmitter system (n = 3;
GABRA5, GABRB2, GABRB2), glutamatergic excitatory
neurotransmitter system (n = 2; SLC1A2, SLC1A3), HPA
axis (n = 1; CRHR1), cannabinoid system (n = 1; CNR1),
cholesterol transport (n = 1; ABCG1), neural growth
and differentiation (n = 2; BDNF &NTRK2)w e r ea l s o
selected (see Additional Fil e1 ) .I nt o t a l ,2 8S N P sp r e -
sent within our 18 candidate genes were identified. The
majority of SNPs (24/28 SNPs) had previous evidence of
association with suicidal behaviour and/or associated
disorders or endophenotypes (see Additional File 1).
Genetic variants and suicide attempts
Results of basic allelic and genotypic tests of association
for each SNP and SA are illustrated in Table 2. Basic
allelic and genotypic association analyses revealed two
significant associations with SA; rs4755404 (Intronic
region of SLC1A2; P = 0.024: Chi-square test) and
rs6296 (Promoter CpG island of 5-HTR1B;P=0 . 0 4 7 :
Chi-square test) loci. In addition a third SNP, rs2269272
(3’untranslated region (UTR)) in SLC1A3; P = 0.075:
Chi-square test), with a P value < 0.1 was chosen for
further analyses. Next, four genotype models (Additive,
Dominant, Over-Dominant and Recessive) were tested
for association with attempter status at each locus
(Table 3).
Rs4755404 yielded evidence of association in an addi-
tive and dominant genotype model (P = 0.029: Exact
Armitage Trends test; P = 0.026: Chi-square test,
respectively), where patients with a G/C or G/G geno-
t y p ew e r es i g n i f i c a n t l ym o r el i k e l yt ob ep r e s e n ti nt h e
SA group. Variation at the rs6296 locus was associated
with SA in an over-dominant genotype model, whereby
a heterozygote (C/G) genotype was more frequently pre-
sent in patients in the SA group than non-attempter
group (P = 0.028). Rs2269272 variants revealed evidence
of association in a recessive genotype model (P = 0.042;
Chi-square test), with the T/T genotype more frequent
in the non-attempter group than attempter group
(Table 3).
SNPs of interest were investigated for possible associa-
tions with other clinical variables illustrated in Table 1.
SNP rs2269272 showed no evidence of association with
other clinical variables in the study. A dominant geno-
type at the rs4755404 locus was associated with patients
with a history of schizophrenia and other psychotic dis-
orders (P = 0.012; Chi-square test). A recessive genotype
at the rs6296 locus yielded an association with
individuals who abuse/depend on alcohol (p = 0.035).
Binary logistical regression analyses were performed to
evaluate the contribution of individual risk/protective
Table 2 Association of candidate markers
Gene Symbol Allele RS number Significance (p)
Allelic Genotypic
SLC1A3 C/T rs2269272 0.562 0.075
HTR1B C/G rs6296 0.895 0.047
SLC1A2 G/C rs4755404 0.024 0.069
COMT G/A rs4680 0.123 0.205
HTR2A G/A rs6313 0.696 0.568
C/T rs6311 0.628 0.307
HTR1A C/G rs6295 0.714 0.907
TPH1 G/T rs1799913 0.136 0.192
G/T rs1800532 0.136 0.192
TPH2 A/G rs7305115 0.647 0.559
DBH T/C rs2519152 0.377 0.761
CNR1 T/G rs6454674 0.948 0.986
T/C rs806368 0.695 0.885
G/A rs6801844 0.883 0.612
BDNF C/T rs6265 0.422 0.650
ABCG1 A/G rs1044317 0.261 0.397
C/G rs225374 0.631 0.823
C/G rs914189 0.862 0.986
GABRG2 C/A rs211014 0.398 0.180
GABRB2 A/G rs1816072 0.270 0.276
C/T rs2491397 0.310 0.594
NTRK2 A/G rs1659400 0.453 0.474
G/A rs1187272 0.137 0.388
CRHR1 A/G rs110402 0.805 0.763
T/G rs242924 0.935 0.463
C/T rs7209436 0.852 0.872
MAOA T/G rs1799835 NA NA
GABRA5 A/G rs140681 NA NA
P value obtained from Pearson’s Chi-square test or Fisher’s exact test. NA =
not applicable, as genotype are identical for case and controls.
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After controlling for possible confounders such as age,
gender, alcohol abuse/dependence (rs6296 only) and
schizophrenia (rs4755404 only), rs2269272 recessive
genotype model was no longer a significant predictor of
SA (P0.121; Odds ratio (OR) = 0.83, 95% C.I: .022-
1.563). Rs4755404 dominant genotype model and rs6296
over-dominant genotype model were still significant pre-
dictors of SA (P = 0.031; OR = 2.198; 95% CI 1.059-
4.563 and P = 0.023; OR = 2.244; 95% CI 1.096-4.597,
respectively).
Each locus was also analysed for deviations from
HWE. Deviations from HWE were observed at the
rs6296 locus in the non-attempter group (P = 0.004)
and at rs2269272 locus in the non-attempter group (P =
0.014).
Genetic and environmental interaction analysis
Individual SNPs were analysed for evidence of gene by
sex interaction, to identify possible sex-specific associa-
tions with SA. Two gene-sex interactions were observed.
A sex by rs2269272 interaction was found where a T/T
genotype was more frequent in non-attempter male SA
group. A gene by sex interaction was also observed for
an intronic SNP, rs1659400, in the NTRK2 gene. Con-
trolling for age, a C/C genotype at this locus was a
significant predictor of SA in females (P = 0.048; OR =
2.968; 95% C.I 1.01- 8.72).
Finally, we investigated the effect of susceptibility loci
on suicide attempts by other susceptibility loci by exam-
ining various two and three way G×G interactions.
Logistic regression was used to model SA risk as a func-
tion of the genotype models associated with SA at each
locus and 2-locus and 3-locus G×G interactions
(Table 4). Controlling for possible confounders, age,
gender, alcohol abuse/dependence and schizophrenia, a
3-locus gene (G×G×G) interaction (rs6296 (C/G) ×
rs4755404 (C/G or G/G) × rs1659400 (C/C) was a sig-
nificant predictor of SA (P = 0.046).
To evaluate further the association between suscept-
ibility genotypes only and environmental risk factors,
logistic regression was used to model risk as a function
of the genotype models associated with SA at each
locus, environmental risk factors and their interaction.
Results provide evidence of a possible G (C/C genotype)
× E (history of childhood abuse (both physical and sex-
ual)) interaction at the rs1659400 locus. Interestingly,
rs1659400 was not associated with SA (p = 0.823, Chi-
square), however when all variables (including gender
and age) are entered into a logistic regression analysis,
the G×E interaction term is close to significance
(P = 0.056, Table 5). Moreover, since a C/C genotype
Table 3 Genotype frequencies and genetic models of association
Genotype Frequencies Significance (p value)
Gene symbol RS number Genotype Controls SA cases Additive Dominant Over-Dominant Recessive
SLC1A3 rs2269272 CC/CT/TT 0.687/0.229/0.084 0.667/0.32/0.013 0.56 0.787 0.199 0.042
HTR1B rs6296 GG/CG/CC 0.59/0.265/0.145 0.5/0.432/0.068 0.847 0.256 0.028 0.121
SLC1A2 rs4755404 CC/CG/GG 0.451/0.427/0.122 0.28/0.52/0.20 0.029 0.026 0.243 0.182
P value obtained from Pearson’s Chi-square test for all genotype tests, with the exception of the additive model, where an exact Armitage trend test was used.
Numbers highlighted in bold represent genotype models that were significantly associated with Suicide attempt status (P = < 0.05). SA: Suicide Attempt.
Table 4 Final gene by gene interaction model: Logistic regression analysis
95% C.I for OR
Variable B S.E Wald df P value OR Lower Upper
Age -.043 .015 8.305 1 .004 .958 .930 .986
Sex -1.062 .422 6.349 1 .012 .346 .151 .790
alcohol abuse/dependence 1.164 .422 7.598 1 .006 3.204 1.400 7.333
schizophrenia and other psychotic disorders - 0.139 .810 .029 1 .864 .870 .178 4.257
rs6296 1.104 .868 1.615 1 .204 3.015 .550 16.539
rs4755404 1.291 .593 4.736 1 .030 3.636 1.137 11.628
rs1659400 .953 .934 1.041 1 .308 2.592 .416 16.159
rs6296 by rs4755404 -1.141 1.065 1.150 1 .284 .319 .040 2.573
rs6296 by rs1659400 -1.356 1.440 .887 1 .346 .258 .015 4.332
rs1659400 by rs4755404 -2.060 1.139 3.275 1 .070 .127 .014 1.187
rs6296 by rs4755404 by rs1659400 3.613 1.811 3.982 1 .046 37.087 1.067 1289.592
Constant .592 .778 .579 1 .447 1.808
B, unstandardised logistic regression coefficient; S.E, Standard error; Wald, Wald statistic; df, Degrees of freedom; OR, Odds ratio; C.I., Confidence interval
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examined in females only. A G×E interaction contribu-
ted to the predictive ability of the model (P = 0.054,
Table 5), a trend which did not reach statistical signifi-
cance. Taken together our results suggest that indivi-
duals who experienced childhood abuse (physical or
sexual) and have a C/C genotype at the rs1659400 locus
may be more susceptible to SA.
Discussion
We have identified 4 SNPs (rs4755404, rs2269272,
rs6296 and rs1659400) in genes SLC1A2, SLC1A3, 5-
HTR1B and NTRK2, respectively, which showed evi-
dence of association with SA compared to a non-
attempter psychiatric control group. At present, there
is no published data on 3/4 of the genetic variants
(rs4755404, rs2269272 and rs1659400) reported here
and their association with suicide or SA. In addition,
we identified a 3-locus (rs6296 (C/G) × rs4755404 (C/
G or G/G) × rs1659400 (C/C)) G×G interaction, which
was a significant predictor of SA, suggesting that varia-
tion in SLC1A2, 5-HTR1B and NTRK2 genes may con-
tribute to the risk of SA independently, and in an
interactive manner. This paper provides evidence for
the first time of a putative G×E interaction, where
genetic variation at the rs1659400 locus may moderate
the risk associated with history of childhood abuse and
subsequent suicidal acts.
SLC1A2 and SLC1A3 are glial high-affinity transporter
molecules that regulate glutamate concentrations at
synapses [15]. Aberrant expression of these key
transporters could impair reuptake of glutamate, hence
prolong synaptic activation and potentially lead to cyto-
toxic damage to neurons and glia [15]. SLC1A2 and
SLC1A3 are downregulated in the brains of MDD
patients compared to controls [28]. Moreover, decreased
SLC1A3 expression has been observed in suicide brains
[29].
In this study, the SLC1A2 gene variant, rs4755404, was
associated with SA and schizophrenia and other psycho-
tic disorders. Consistent with these findings, rs4755404
was previously associated with schizophrenia in a Japa-
nese patient cohort [30]. In contrast, the SLC1A3 gene
variant, rs2269272, was significantly associated with
male non-attempters, where a gene-sex interaction was
observed. The T/T genotype is absent from the attemp-
ter group and over-represented in the male non-attemp-
ter group, suggesting a T/T genotype may confer a
protective effect on risk of SA, particularly in males
with underlying psychiatric disorders. HWE analysis
revealed that the control gro u pw a sn o ti ne q u i l i b r i u m
for the rs2269272 locus, which is likely due to the fact
that our control group is not “disease-free” but rather
consists of individuals with underlying psychiatric condi-
tions. However, the possibility that some other factor
may be influencing the over-representation of T allele
homozygotes in the non-attempter group cannot be
ruled out. Therefore, further investigation in a larger
cohort of patients is warranted. Taken together, our
findings support the glial hypothesis of mood abnormal-
ities [28] and concur with the literature on a putative
role of glutamate dysregulation in suicidal behaviour.
The serotonin (5-HT) system is the most widely stu-
died area of neurobiological suicide research [21]. Aber-
rant 5-HT receptor binding has been implicated in
suicide and SA [12]. 5-HTR1B binding is decreased in
the prefrontal cortex of suicide brains [31]. Previously a
5-HTR1B promoter CpG island genetic variant, rs6296,
was associated with SA [32]. However, findings are
inconsistent and a number of studies have found no evi-
dence of association [33,34]. Rs6296 has also been asso-
ciated with substance use disorders, major depression
and inconsistently with alcohol abuse [33,35]. Here we
report a significant association between the rs6296 locus
and SA. In addition, persons with a C/G genotype and a
history of abuse or dependence on alcohol were signifi-
cantly associated with SA, but a gene × alcohol interac-
tion was not evident, suggesting that they represent
additive risk factors. These findings provide the impetus
for future studies in a cohort of alcohol abuse/depen-
dence patients to further understand the relevance of
rs6296 genetic variants and SA in patients with a history
of alcohol abuse/dependence.
NTRK2 (TRKB) encodes the receptor for BDNF. Aber-
rant neurotrophic signalling has been implicated in
Table 5 Gene by environment interaction: Logistic
regression analysis
95% C.I for OR
Variable B S.E Wald df P
value
OR Lower Upper
Sex -.384 .358 1.152 1 .283 .681 .338 1.373
Age -.035 .013 7.669 1 .006 .965 .941 .990
rs1659400 -.038 .426 .008 1 .928 .962 .417 2.219
abuse -.508 .469 1.175 1 .278 .602 .240 1.508
rs1659400 by
abuse
1.518 .795 3.641 1 .056 4.562 .960 21.684
Constant 1.406 .627 5.035 1 .025 4.079
Females
Only
Age -.025 .018 1.911 1 .167 .975 .941 1.010
rs1659400 .166 .634 .068 1 .794 1.181 .341 4.093
abuse .003 .774 .000 1 .997 1.003 .220 4.571
rs1659400 by
abuse
2.653 1.378 3.707 1 .054 14.202 .953 211.572
Constant .633 .848 .556 1 .456 1.883
B, unstandardised logistic regression coefficient; S.E, Standard Error; Wald,
Wald statistic; df, degrees of freedom; OR, Odds ratio; C.I., Confidence interval
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NTRK2 mRNA and protein expression are reported
downregulated in the prefrontal cortex and hippocam-
pus of suicide victims compared to controls [36,37]. The
majority of studies have focused on functional BDNF
variant, rs6265, which has been inconsistently implicated
in suicide and MDD [38,39]. In this study, we found no
evidence of association between rs6265 and SA, consis-
tent with a previous report [40]. Previously, a number of
genetic variants within the NTRK2 gene have been asso-
ciated with SA among depressed patients [41]. We
observed a significant association with NTRK2 intronic
genetic variant, rs1659404, and SA in females.
Rs1659400 is in strong LD with several other SNPs
within the NTRK1 gene, some of which have been
implicated in alcohol dependence and depression
[42,43].
To date a number of gene × childhood adversity inter-
actions have been reported in psychiatric patients
[44-46]. Childhood trauma (including abuse) has been
reported to interact with low expressing 5-HTTLPR gen-
otypes and moderate the risk of suicidal behaviour [47].
Recently, an interaction between child maltreatment and
5-HTT polymorphisms and suicidal ideation among chil-
dren was described [48]. Here we report, for the first
time, a possible moderation effect of a NTRK2 poly-
morphism on childhood abuse and risk for future suici-
dal acts. It is important to note that a history of
childhood abuse was assessed in this study by a trained
clinician as opposed to self-report questionnaires.
Recent research has demonstrated that clinician ratings
of developmental histories, such as childhood sexual and
physical abuse, are in agreement with patient’ss e l f -
reports and thus supports the validity of clinician
reports for numerous clinical variables, including child-
hood abuse assessment [49]. Future studies could inves-
tigate the putative interaction of this genetic variant
with childhood trauma score, which would include sex-
ual, physical and emotional abuse and neglect. Such a
s t u d yw o u l dp r o v i d eam o r ec o m p r e h e n s i v ea s s e s s m e n t
of gene × childhood adversity interaction and risk for
SA at this locus.
A number of limitations are apparent in the current
study. Firstly, case/control samples were not age-
matched, with the SA group having a significantly
younger mean age. The SA group also contained a
greater number of individuals with a family history of
SA and a history of childhood abuse. In addition, rates
of MDD diagnoses were different in SA and non-
attempter psychiatric controls. However, the genetic var-
iants identified in this study were not associated with
either MDD, a family history of SA or abuse. Moreover,
our sample size may have reduced power to detect small
genetic effects, or alternative interactions between
genetic and environmental risk factors. In this study,
multiple testing correction, such as Bonferroni correc-
tion, was not applied. Bonferroni correction can be
regarded as ultraconservative [50] and ignores the func-
tional candidate gene study design utilised, which is
likely to increase the prior probability of detecting an
association. In addition, given our modest sample size,
Bonferroni correction is likely to result in large type II
error rates. Arguably the best solution to type I error is
replication [50].
Conclusion
I nc o n c l u s i o n ,w eh a v ei d e n t i f ied statistically as well as
biologically significant genetic polymorphisms that may
be relevant to the underlying diathesis for suicidal acts
[1]. An understanding of the functional consequence of
these SNPs from a neuropathological standpoint would
be advantageous to advance our understanding of their
role in SA. The SNP associations identified in this
study, although modest, merit further investigation in a
larger cohort of suicide attempters and may contribute
to future meta-analysis of suicidal behaviour susceptibil-
ity loci. Moreover, follow-up research of the genetic sus-
ceptibly polymorphisms identified in this study may
increase our understanding of the complex relationship
of genetic and environmental factors in suicidal beha-
viour in major psychiatric disorders.
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